Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety

Summary: A challenge in treating glioblastoma (GBM) is its phenotypic heterogeneity between patients and within tumors. Chlorotoxin (CLTX), a peptide from scorpion venom, broadly binds glioma cells through a mechanism involving surface matrix metalloproteinase-2 (MMP-2). We previously developed chim...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Michael E. Barish, Maryam Aftabizadeh, Jonathan Hibbard, M. Suzette Blanchard, Julie R. Ostberg, Jamie R. Wagner, Mishika Manchanda, Jinny Paul, Tracy Stiller, Brenda Aguilar, Renate Starr, Leonidas Arvanitis, Julie A. Ressler, Julie Kilpatrick, Yuthana Kong, Dongrui Wang, Stephen J. Forman, Massimo D’Apuzzo, Christine E. Brown, Behnam Badie
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2025-08-01
Ráidu:	Cell Reports Medicine
Fáttát:	chlorotoxin chimeric antigen receptor T cells immunotherapy phase 1 clinical trial
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S2666379125003751
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!